|

Idelalisib Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 2: 1Phase 3: 2

Top Sponsors

  • Oslo University Hospital1
  • Dizal (Jiangsu) Pharmaceutical Co., Ltd.1
  • BeOne Medicines1

Indications

  • Cancer3
  • CLL1
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma1
  • Chronic Lymphocytic Leukemia1
  • Metastatic Colorectal Cancer1

Other2 trials

A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)
Phase 3
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
Phase 2

Jonesboro, Arkansas1 trial

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

St Bernards Medical Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.